A Phase 1b multiple ascending-dose trial of LX2761 in patients with type 2 diabetes
Phase of Trial: Phase I
Latest Information Update: 20 Dec 2018
At a glance
- Drugs LX 2761 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 20 Dec 2018 Top-line results presented in a Lexicon Pharmaceuticals media release.
- 01 Nov 2018 According to a Lexicon Pharmaceuticals media release, data from this trial is expected in Q4 2018.
- 30 Jul 2018 According to a Lexicon Pharmaceuticals media release, data from this study is expected in 2H of 2018.